Position in IMCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,705,924
+$13,398,224 QoQ
Shares Held
1,597,037
+29.1% QoQ
Ownership
3.10%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#9
of 136 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Derivatives in IMCR
reported options exposure · as of Jun 30, 2025CallValue
$470,700
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. IMCR ranks #19 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in IMCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,705,924 | 1,597,037 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $37,307,700 | 1,237,403 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,641,531 | 911,597 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $45,992,508 | 1,265,965 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $470,700 | 15,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $8,676,632 | 276,502 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,463,960 | 285,270 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,914,179 | 573,362 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,063,523 | 676,631 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,366,331 | 600,954 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,406,155 | 267,787 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,099,063 | 59,998 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,828,925 | 189,382 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $3,114,000 | 60,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $3,897,400 | 65,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $3,213,600 | 65,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $5,814,292 | 117,603 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,274,136 | 337,728 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $3,310,060 | 58,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $7,331,183 | 156,182 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $715,531 | 19,178 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $1,272,271 | 34,100 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $968,760 | 32,400 | Call | Sole | 2022-05-16 | |
| 2021-09-30 | $3,477,610 | 93,812 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,026,875 | 103,121 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,669,593 | 203,655 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||